MedTrace Logo

Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

NCT00644852 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 342

Last updated 2014-05-23

No results posted yet for this study

Summary

The purpose of the study is to evaluate the characteristics, clinical responses, and safety issues of patients receiving long-term treatment of Risperidone long-acting injectable. The goal is to evaluate patient outcomes based on pre-existing risk or disease factors and past medication use.

Conditions

Interventions

OTHER

Retrospective chart review study

Retrospective study chart review long acting risperidone

Sponsors & Collaborators

  • Johnson & Johnson Taiwan Ltd

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Taiwan, Ltd. Clinical Trial · Johnson & Johnson Taiwan Ltd

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-09-30
Completion
2007-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00644852 on ClinicalTrials.gov